Key result
B vitamins and omega-3 fatty acids show no benefit over placebo for major cardiovascular events.
RCT (n=2,501)
Double-blind
Factorial
Yes
Answers are grounded in this paper and cite their sources.
OBJECTIVE: To investigate whether dietary supplementation with B vitamins or omega 3 fatty acids, or both, could prevent major cardiovascular events in patients with a history of ischaemic heart disease or stroke. DESIGN: Double blind, randomised, placebo controlled trial; factorial design. SETTING: Recruitment throughout France via a network of 417 cardiologists, neurologists, and other physicians. PARTICIPANTS: 2501 patients with a history of myocardial infarction, unstable angina, or ischaemic stroke. INTERVENTION: Daily dietary supplement containing 5-methyltetrahydrofolate (560 μg), vitamin B-6 (3 mg), and vitamin B-12 (20 μg) or placebo; and containing omega 3 fatty acids (600 mg of eicosapentanoic acid and docosahexaenoic acid at a ratio of 2:1) or placebo. Median duration of supplementation was 4.7 years. MAIN OUTCOME MEASURES: Major cardiovascular events, defined as a composite of non-fatal myocardial infarction, stroke, or death from cardiovascular disease. RESULTS: Allocation to B vitamins lowered plasma homocysteine concentrations by 19% compared with placebo, but had no significant effects on major vascular events (75 v 82 patients, hazard ratio, 0.90 (95% confidence interval 0.66 to 1.23, P=0.50)). Allocation to omega 3 fatty acids increased plasma concentrations of omega 3 fatty acids by 37% compared with placebo, but also had no significant effect on major vascular events (81 v 76 patients, hazard ratio 1.08 (0.79 to 1.47, P=0.64)). CONCLUSION: This study does not support the routine use of dietary supplements containing B vitamins or omega 3 fatty acids for prevention of cardiovascular disease in people with a history of ischaemic heart disease or ischaemic stroke, at least when supplementation is introduced after the acute phase of the initial event. TRIAL REGISTRATION: Current Controlled Trials ISRCTN41926726.
No takes yet. Share an insight, caveat, or question.
Galán et al. (2010) conducted an RCT in History of ischaemic heart disease or stroke (n=2,501). B vitamins (5-methyltetrahydrofolate, vitamin B-6, vitamin B-12) and/or omega 3 fatty acids (EPA and DHA) vs. Placebo was evaluated on Major cardiovascular events, defined as a composite of non-fatal myocardial infarction, stroke, or death from cardiovascular disease (HR 0.90, 95% CI 0.66-1.23, p=0.50). Dietary supplementation with B vitamins or omega-3 fatty acids did not reduce major cardiovascular events versus placebo.
Synapse has enriched 10 related papers. Consider them for comparative context: